N-lauroyl chitosan surface-modified PLGA nanoparticles as carrier for adriamycin to overcome cancer drug resistance

References

• Allison SD. Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic) acid microparticle drug delivery systems. J Pharm Sci, 2008;97:2022–35
   PubMed Web of Science ®Google Scholar
• Amiji MM. Pyrene flourescence study of chitosan self-association in aqueous solution. Carbohydr Polym, 1995;26:211–13
   Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 1997;28:5–24
   PubMed Web of Science ®Google Scholar
• Angadi SC, Manjeshwar LS, Aminabhavi TM. Interpenetrating polymer network blend microspheres of chitosan and hydroxyethyl cellulose for controlled release of isoniazid. Int J Biol Macromol, 2010;47:171–9
   PubMed Web of Science ®Google Scholar
• Angadi SC, Manjeshwar LS, Aminabhavi TM. Stearic acid-coated chitosan-based interpenetrating polymer network microspheres: controlled release characteristics. Ind Eng Chem Res, 2011;50:4504–14
   Web of Science ®Google Scholar
• Bakhru SH, Altiok E, Highley C, Delubac D, Suhan J, Hitchens TK, Ho C, Zappe S. Enhanced cellular uptake and long-term retention of chitosan-modified iron-oxide nanoparticles for MRI-based cell tracking. Int J Nanomedicine, 2012;7:4613–23
   PubMed Web of Science ®Google Scholar
• Chen H-L, Tang H-B, Yang W-Z, Chen H, Wang Y-S, Mei L, Zhang T, Xiong Q-Q, Zhang Q-Q. Preparation and characterization of PLGA nanospheres surface modified with biotinylated chitosan. Chem J Chin U, 2010;31:1682–7
   Google Scholar
• Chen H, Yang W, Chen H, Liu L, Gao F, Yang X, Jiang Q, Zhang Q, Wang Y. Surface modification of mitoxantrone-loaded PLGA nanospheres with chitosan. Colloids Surf B: Biointerfaces, 2009;73:212–18
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release, 2010;148:135–46
   PubMed Web of Science ®Google Scholar
• Duan Y, Sun X, Gong T, Wang Q, Zhang Z. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo. J Mater Sci Mater Med, 2006;17:509–16
   PubMed Web of Science ®Google Scholar
• Freese C, Gibson MI, Klok HA, Unger RE, Kirkpatrick CJ. Size- and coating-dependent uptake of polymer-coated gold nanoparticles in primary human dermal microvascular endothelial cells. Biomacromolecules, 2012;13:1533–43
   PubMed Web of Science ®Google Scholar
• Guo C, Gemeinhart RA. Understanding the adsorption mechanism of chitosan onto poly(lactide-co-glycolide) particles. Eur J Pharm Biopharm, 2008;70:597–604
   PubMed Web of Science ®Google Scholar
• Hirano S, Yamaguchi Y, Kamiya M. Novel N-saturated-fatty-acyl derivatives of chitosan soluble in water and in aqueous acid and alkaline solutions. Carbohydr Polym, 2002;48:203–7
   Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 2000;21:2475–90
   PubMed Web of Science ®Google Scholar
• Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev, 2004;104:6017–84
   PubMed Web of Science ®Google Scholar
• Lee MS, Hong KJ, Kajiuchi T, Yang J-W. Synthesis of chitosan-based polmeric surfactants and their adsorption properties for heavy metals and fatty acids. Int J Biol Macromol, 2005;36:152–8
   PubMed Web of Science ®Google Scholar
• Leonessa F, Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer, 2003;10:43–73
   PubMed Web of Science ®Google Scholar
• Le Ray AM, Vert M, Gautier JC, Benoıt JP. Fate of [14C] poly(-lactide-co-glycolide) nanoparticles after intravenous and oral administration to mice. Int J Pharm, 1994;106:201–11
   Web of Science ®Google Scholar
• Liang GF, Zhu YL, Sun B, Hu FH, Tian T, Li SC, Xiao ZD. PLGA-based gene delivering nanoparticle enhance suppression effect of miRNA in HePG2 cells. Nanoscale Res Lett, 2011;6:447 . Available at: http://www.nanoscalereslett.com/content/6/1/447
   PubMedGoogle Scholar
• Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm, 2009;71:409–19
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release, 2001;74:47–61
   PubMed Web of Science ®Google Scholar
• Mahapatro1 A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol, 2011;9:55 . Available at: http://www.jnanobiotechnology.com/content/9/1/55
   PubMedGoogle Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers, 2011;3:1377–97
   PubMed Web of Science ®Google Scholar
• Mohamed F, van der Walle CF. Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci, 2008;97:71–87
   PubMed Web of Science ®Google Scholar
• Mundargi R, Babu V, Rangaswamy V, Patel P, Aminabhavi T. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J Control Release, 2008;125:193–209
   PubMed Web of Science ®Google Scholar
• Patel MP, Patel RR, Patel JK. Chitosan mediated targeted drug delivery system: A review. J Pharm Pharm Sci, 2010;13:536–57
   PubMed Web of Science ®Google Scholar
• Ray SD. Potential aspects of chitosan as pharmaceutical excipient. Acta Pol Pharm, 2011;68:619–22
   PubMed Web of Science ®Google Scholar
• Stolnik S, Dunn SE, Garnett MC, Davies MC, Coombes AG, Taylor DC, Irving MP, Purkiss SC, Tadros TF, Davis SS, et al. Surface modification of poly (lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res, 1994;11:1800–8
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang X, Yang J, Wang Y, Chen R, Wu J, Liu Y, Zhang N. Self-assembled nanoparticlesof methotrexate conjugated O-carboxymethyl chitosan: Preparation, characterization and drug release behavior in vitro. Carbohydr Polym, 2011;86:1665–70
   Web of Science ®Google Scholar
• Whilhelm M, Zhao C, Wang Y, Xu R, Winnik MA, Mura J. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: A flourescence probe study. Macromolecules, 1991;24:1033–44
   Google Scholar
• Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Int J Pharm, 2009;371:142–7
   PubMed Web of Science ®Google Scholar
• Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery. Pharm Res, 2010;27:1285–95
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhang L, Zhang B, Wei X, Yang Y, Qi RZ, Ying G, Zhang N, Liu R. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells. J Proteome Res, 2009;8:5041–7
   PubMedGoogle Scholar